Ongoing Disclosure Notice – Various

Ongoing Disclosure Notice
Disclosure of Directors and Senior Managers Relevant Interests
Sections 297(2) and 298(2), Financial Markets Conduct Act 2013
To NZX Limited; and
Name of listed issuer:
Heartland Group Holdings Limited
Date this disclosure made:
3 May 2024
Date of last disclosure:
26 September 2023
Director or senior manager giving disclosure
Full name(s):
Andrew Peter Dixson
Name of listed issuer:
Heartland Group Holdings Limited
Name of related body corporate (if applicable):
Not applicable
Position held in listed issuer:
Chief Financial Officer
Summary of acquisition or disposal of relevant interest (excluding specified derivatives)
Class of affected quoted financial products:
Ordinary shares in Heartland Group
Holdings Limited (NZX/ASX: HGH)
Nature of the affected relevant interest(s):
Registered Holder and Beneficial
Owner
For that relevant interest-
Number held in class before acquisition or disposal:
515,584
Number held in class after acquisition or disposal:
550,000
Current registered holder(s):
Andrew Peter Dixson
Registered holder(s) once transfers are registered:
Not applicable
Summary of acquisition or disposal of specified derivatives relevant interest (if applicable)
Type of affected derivative:
Not applicable
Class of underlying financial products:
Not applicable
Details of affected derivative-
The notional value of the derivative (if any) or the notional amount of underlying
financial products (if any):
Not applicable
A statement as to whether the derivative is cash settled or physically settled:
Not applicable
Maturity date of the derivative (if any):
Not applicable
Expiry date of the derivative(if any):
Not applicable
The price specified in the terms of the derivative (if any):
Not applicable
Any other details needed to understand how the amount of the consideration payable
under the derivative or the value of the derivative is affected by the value of the
underlying financial products:
Not applicable
For that derivative,-
Parties to the derivative:
Not applicable
If the director or senior manager is not a party to the derivative, the nature of the
relevant interest in the derivative:
Not applicable
Details of transactions giving rise to acquisition or disposal
Total number of transactions to which notice relates: 1

Details of transactions requiring disclosure-
Date of transaction:26 April 2024
Nature of transaction:
Acquisition of shares under the retail
component of Heartland’s
underwritten NZ$105 million
accelerated non renounceable
entitlement offer announced on 8
April 2024
Name of any other party or parties to the transaction (if known):Not applicable
The consideration, expressed in New Zealand dollars, paid or received for the
acquisition or disposal. If the consideration was not in cash and cannot be readily by
converted into a cash value, describe the consideration:
$34,416.00
Number of financial products to which the transaction related: 34,416
If the issuer has a financial products trading policy that prohibits directors or senior
managers from trading during any period without written clearance (a closed period)
include the following details—
Whether relevant interests were acquired or disposed of during a closed period:No
Whether prior written clearance was provided to allow the acquisition or disposal to
proceed during the closed period:
Not applicable
Date of the prior written clearance (if any):
Not applicable
Summary of other relevant interests after acquisition or disposal:
Class of quoted financial products:Not applicable
Nature of relevant interest:Not applicable
For that relevant interest,-
Number held in class:Not applicable
Current registered holder(s):Not applicable
For a derivative relevant interest,-
Type of derivative:Not applicable
Details of derivative,-
The notional value of the derivative (if any) or the notional amount of underlying
financial products (if any):
Not applicable
A statement as to whether the derivative is cash settled or physically settled:
Not applicable
Maturity date of the derivative (if any):
Not applicable
Expiry date of the derivative (if any):
Not applicable
The price's specified terms (if any):
Not applicable
Any other details needed to understand how the amount of the consideration payable
under the derivative or the value of the derivative is affected by the value of the
underlying financial products:
Not applicable
For that derivative relevant interest,-
Parties to the derivative:
Not applicable
If the director or senior manager is not a party to the derivative, the nature of the
relevant interest in the derivative:
Not applicable
Certification
I, certify that, to the best of my knowledge and belief, the information contained in this
disclosure is correct and that I am duly authorised to make this disclosure by all
persons for whom it is made.
Signature of director or officer:
Date of signature:
or

Signature of person authorised to sign on behalf of director or officer:
Date of signature:
3 May 2024
Name and title of authorised person:Phoebe Gibbons, General Counsel

Ongoing Disclosure Notice
Disclosure of Directors and Senior Managers Relevant Interests
Sections 297(2) and 298(2), Financial Markets Conduct Act 2013
To NZX Limited; and
Name of listed issuer:
Heartland Group Holdings Limited
Date this disclosure made:
3 May 2024
Date of last disclosure:
8 May 2023
Director or senior manager giving disclosure
Full name(s):
Bruce Robertson Irvine
Name of listed issuer:
Heartland Group Holdings Limited
Name of related body corporate (if applicable):
Heartland Bank Limited
Position held in listed issuer:
Director
Summary of acquisition or disposal of relevant interest (excluding specified derivatives)
Class of affected quoted financial products:
Ordinary shares in Heartland Group
Holdings Limited (NZX/ASX: HGH)
Nature of the affected relevant interest(s):
(a) Registered Holder and Beneficial
Owner
(b) Beneficial Owner
For that relevant interest-
Number held in class before acquisition or disposal:
(a) 166,573 (b) 532,829
Number held in class after acquisition or disposal:
(a) 215,207 (b) 688,399
Current registered holder(s):
(a) Bruce Robertson Irvine
(b) Mary Therese Irvine
Registered holder(s) once transfers are registered:
Not applicable
Summary of acquisition or disposal of specified derivatives relevant interest (if applicable)
Type of affected derivative:
Not applicable
Class of underlying financial products:
Not applicable
Details of affected derivative-
The notional value of the derivative (if any) or the notional amount of underlying
financial products (if any):
Not applicable
A statement as to whether the derivative is cash settled or physically settled:
Not applicable
Maturity date of the derivative (if any):
Not applicable
Expiry date of the derivative(if any):
Not applicable
The price specified in the terms of the derivative (if any):
Not applicable
Any other details needed to understand how the amount of the consideration payable
under the derivative or the value of the derivative is affected by the value of the
underlying financial products:
Not applicable
For that derivative,-
Parties to the derivative:
Not applicable
If the director or senior manager is not a party to the derivative, the nature of the
relevant interest in the derivative:
Not applicable
Details of transactions giving rise to acquisition or disposal
Total number of transactions to which notice relates: 2

Details of transactions requiring disclosure-
Date of transaction:26 April 2024
Nature of transaction:
Acquisition of shares under the retail
component of Heartland’s
underwritten NZ$105 million
accelerated non renounceable
entitlement offer announced on 8
April 2024
Name of any other party or parties to the transaction (if known):Not applicable
The consideration, expressed in New Zealand dollars, paid or received for the
acquisition or disposal. If the consideration was not in cash and cannot be readily by
converted into a cash value, describe the consideration:
(a) $48,634.00 (b) $155,570.00
Number of financial products to which the transaction related: (a) 48,634 (b) 155,570
If the issuer has a financial products trading policy that prohibits directors or senior
managers from trading during any period without written clearance (a closed period)
include the following details—
Whether relevant interests were acquired or disposed of during a closed period:No
Whether prior written clearance was provided to allow the acquisition or disposal to
proceed during the closed period:
Not applicable
Date of the prior written clearance (if any):
Not applicable
Summary of other relevant interests after acquisition or disposal:
Class of quoted financial products:
Unsecured, subordinated Notes in
Heartland Bank Limited (NZX: HBL)
Nature of relevant interest:
(a) Beneficial Owner (b)
Beneficial Owner
For that relevant interest,-
Number held in class:
(a) 50,000 (b)
50,000
Current registered holder(s):
(a) Mary Therese Irvine (b)
Bruce Robertson Irvine, David John
Strack and Stephen John Bryne as
trustees of the Lake Angelus Trust
For a derivative relevant interest,-
Type of derivative:Not applicable
Details of derivative,-
The notional value of the derivative (if any) or the notional amount of underlying
financial products (if any):
Not applicable
A statement as to whether the derivative is cash settled or physically settled:Not applicable
Maturity date of the derivative (if any):Not applicable
Expiry date of the derivative (if any):Not applicable
The price's specified terms (if any):Not applicable
Any other details needed to understand how the amount of the consideration payable
under the derivative or the value of the derivative is affected by the value of the
underlying financial products:
Not applicable
For that derivative relevant interest,-
Parties to the derivative:
Not applicable
If the director or senior manager is not a party to the derivative, the nature of the
relevant interest in the derivative:
Not applicable
Certification

I, certify that, to the best of my knowledge and belief, the information contained in this
disclosure is correct and that I am duly authorised to make this disclosure by all
persons for whom it is made.
Signature of director or officer:
Date of signature:
or
Signature of person authorised to sign on behalf of director or officer:
Date of signature:
3 May 2024
Name and title of authorised person:Phoebe Gibbons, General Counsel

Ongoing Disclosure Notice
Disclosure of Directors and Senior Managers Relevant Interests
Sections 297(2) and 298(2), Financial Markets Conduct Act 2013
To NZX Limited; and
Name of listed issuer:
Heartland Group Holdings Limited
Date this disclosure made:
3 May 2024
Date of last disclosure:
23 September 2022
Director or senior manager giving disclosure
Full name(s):
Christopher Patrick Francis Flood
Name of listed issuer:
Heartland Group Holdings Limited
Name of related body corporate (if applicable):
Not applicable
Position held in listed issuer:
Deputy Group Chief Executive
Officer
Summary of acquisition or disposal of relevant interest (excluding specified derivatives)
Class of affected quoted financial products:
Ordinary shares in Heartland Group
Holdings Limited (NZX/ASX: HGH)
Nature of the affected relevant interest(s):
Registered Holder and Beneficial
Owner
For that relevant interest-
Number held in class before acquisition or disposal:
(a) 1,819,706 (b) 42,360
Number held in class after acquisition or disposal:
(a) 2,127,706 (b) 54,360
Current registered holder(s):
(a) Christopher Patrick Francis Flood
(b) Christopher Patrick Francis Flood
& Nicola Anne Moloney & Lane
Neave Trustees Limited
Registered holder(s) once transfers are registered:
Not applicable
Summary of acquisition or disposal of specified derivatives relevant interest (if applicable)
Type of affected derivative:
Not applicable
Class of underlying financial products:
Not applicable
Details of affected derivative-
The notional value of the derivative (if any) or the notional amount of underlying
financial products (if any):
Not applicable
A statement as to whether the derivative is cash settled or physically settled:
Not applicable
Maturity date of the derivative (if any):
Not applicable
Expiry date of the derivative(if any):
Not applicable
The price specified in the terms of the derivative (if any):
Not applicable
Any other details needed to understand how the amount of the consideration payable
under the derivative or the value of the derivative is affected by the value of the
underlying financial products:
Not applicable
For that derivative,-
Parties to the derivative:
Not applicable
If the director or senior manager is not a party to the derivative, the nature of the
relevant interest in the derivative:
Not applicable
Details of transactions giving rise to acquisition or disposal
Total number of transactions to which notice relates: 2

Details of transactions requiring disclosure-
Date of transaction:26 April 2024
Nature of transaction:
Acquisition of shares under the retail
component of Heartland’s
underwritten NZ$105 million
accelerated non renounceable
entitlement offer announced on 8
April 2024
Name of any other party or parties to the transaction (if known):Not applicable
The consideration, expressed in New Zealand dollars, paid or received for the
acquisition or disposal. If the consideration was not in cash and cannot be readily by
converted into a cash value, describe the consideration:
(a) $308,000.00 (b) $12,000.00
Number of financial products to which the transaction related: (a) 308,000 (b) 12,000
If the issuer has a financial products trading policy that prohibits directors or senior
managers from trading during any period without written clearance (a closed period)
include the following details—
Whether relevant interests were acquired or disposed of during a closed period:No
Whether prior written clearance was provided to allow the acquisition or disposal to
proceed during the closed period:
Not applicable
Date of the prior written clearance (if any):
Not applicable
Summary of other relevant interests after acquisition or disposal:
Class of quoted financial products:Not applicable
Nature of relevant interest:Not applicable
For that relevant interest,-
Number held in class:Not applicable
Current registered holder(s):Not applicable
For a derivative relevant interest,-
Type of derivative:Not applicable
Details of derivative,-
The notional value of the derivative (if any) or the notional amount of underlying
financial products (if any):
Not applicable
A statement as to whether the derivative is cash settled or physically settled:
Not applicable
Maturity date of the derivative (if any):
Not applicable
Expiry date of the derivative (if any):
Not applicable
The price's specified terms (if any):
Not applicable
Any other details needed to understand how the amount of the consideration payable
under the derivative or the value of the derivative is affected by the value of the
underlying financial products:
Not applicable
For that derivative relevant interest,-
Parties to the derivative:
Not applicable
If the director or senior manager is not a party to the derivative, the nature of the
relevant interest in the derivative:
Not applicable
Certification
I, certify that, to the best of my knowledge and belief, the information contained in this
disclosure is correct and that I am duly authorised to make this disclosure by all
persons for whom it is made.
Signature of director or officer:
Date of signature:
or
Signature of person authorised to sign on behalf of director or officer:

Date of signature:
3 May 2024
Name and title of authorised person:Phoebe Gibbons, General Counsel

Ongoing Disclosure Notice
Disclosure of Directors and Senior Managers Relevant Interests
Sections 297(2) and 298(2), Financial Markets Conduct Act 2013
To NZX Limited; and
Name of listed issuer:
Heartland Group Holdings Limited
Date this disclosure made:
3 May 2024
Date of last disclosure:
2 November 2022
Director or senior manager giving disclosure
Full name(s):
Geoffrey Edward Summerhayes
Name of listed issuer:
Heartland Group Holdings Limited
Name of related body corporate (if applicable):
Not applicable
Position held in listed issuer:
Director
Summary of acquisition or disposal of relevant interest (excluding specified derivatives)
Class of affected quoted financial products:
Ordinary shares in Heartland Group
Holdings Limited (NZX/ASX: HGH)
Nature of the affected relevant interest(s):
Registered Holder and Beneficial
Owner
For that relevant interest-
Number held in class before acquisition or disposal:
(a) 20000 (b) 25838
Number held in class after acquisition or disposal:
(a) 25838 (b) 55838
Current registered holder(s):
Geoffrey Edward Summerhayes
Registered holder(s) once transfers are registered:
Not applicable
Summary of acquisition or disposal of specified derivatives relevant interest (if applicable)
Type of affected derivative:
Not applicable
Class of underlying financial products:
Not applicable
Details of affected derivative-
The notional value of the derivative (if any) or the notional amount of underlying
financial products (if any):
Not applicable
A statement as to whether the derivative is cash settled or physically settled:
Not applicable
Maturity date of the derivative (if any):
Not applicable
Expiry date of the derivative(if any):
Not applicable
The price specified in the terms of the derivative (if any):
Not applicable
Any other details needed to understand how the amount of the consideration payable
under the derivative or the value of the derivative is affected by the value of the
underlying financial products:
Not applicable
For that derivative,-
Parties to the derivative:
Not applicable
If the director or senior manager is not a party to the derivative, the nature of the
relevant interest in the derivative:
Not applicable
Details of transactions giving rise to acquisition or disposal
Total number of transactions to which notice relates: 2

Details of transactions requiring disclosure-
Date of transaction:(a) 26/04/2024 (b) 1/5/2024
Nature of transaction:
(a) Acquisition of shares under the
retail component of Heartland’s
underwritten NZ$105 million
accelerated non renounceable
entitlement offer announced on 8
April 2024 (b) Acquisition of shares
on-market
Name of any other party or parties to the transaction (if known):Not applicable
The consideration, expressed in New Zealand dollars, paid or received for the
acquisition or disposal. If the consideration was not in cash and cannot be readily by
converted into a cash value, describe the consideration:
(a) 5838 (b) c. 32,032
Number of financial products to which the transaction related: (a) 5838 (b) 30,000
If the issuer has a financial products trading policy that prohibits directors or senior
managers from trading during any period without written clearance (a closed period)
include the following details—
Whether relevant interests were acquired or disposed of during a closed period:No
Whether prior written clearance was provided to allow the acquisition or disposal to
proceed during the closed period:
Not applicable
Date of the prior written clearance (if any):
Not applicable
Summary of other relevant interests after acquisition or disposal:
Class of quoted financial products:Not applicable
Nature of relevant interest:Not applicable
For that relevant interest,-
Number held in class:Not applicable
Current registered holder(s):Not applicable
For a derivative relevant interest,-
Type of derivative:Not applicable
Details of derivative,-
The notional value of the derivative (if any) or the notional amount of underlying
financial products (if any):
Not applicable
A statement as to whether the derivative is cash settled or physically settled:
Not applicable
Maturity date of the derivative (if any):
Not applicable
Expiry date of the derivative (if any):
Not applicable
The price's specified terms (if any):
Not applicable
Any other details needed to understand how the amount of the consideration payable
under the derivative or the value of the derivative is affected by the value of the
underlying financial products:
Not applicable
For that derivative relevant interest,-
Parties to the derivative:
Not applicable
If the director or senior manager is not a party to the derivative, the nature of the
relevant interest in the derivative:
Not applicable
Certification
I, certify that, to the best of my knowledge and belief, the information contained in this
disclosure is correct and that I am duly authorised to make this disclosure by all
persons for whom it is made.
Signature of director or officer:
Date of signature:
or

Signature of person authorised to sign on behalf of director or officer:
Date of signature:
3 May 2024
Name and title of authorised person:Phoebe Gibbons, General Counsel

Ongoing Disclosure Notice
Disclosure of Directors and Senior Managers Relevant
Interests
Sections 297(2) and 298(2), Financial Markets Conduct
Act 2013
To NZX Limited; and
Name of listed issuer:
Heartland Group Holdings Limited
Date this disclosure made:
3 May 2024
Date of last disclosure:
25 November 2022
Director or senior manager giving disclosure
Full name(s):
Jeffrey Kenneth Greenslade
Name of listed issuer:
Heartland Group Holdings Limited
Name of related body corporate (if applicable):
Not applicable
Position held in listed issuer:
Director and CEO
Summary of acquisition or disposal of relevant interest (excluding specified derivatives)
Class of affected quoted financial products:
Ordinary shares in Heartland Group
Holdings Limited (NZX/ASX: HGH)
Nature of the affected relevant interest(s):
Registered Holder and Beneficial
Owner
For that relevant interest-
Number held in class before acquisition or disposal:
2,400,514
Number held in class after acquisition or disposal:
2,650,954
Current registered holder(s):
Jeffrey Kenneth Greenslade
Registered holder(s) once transfers are registered:
Not applicable
Summary of acquisition or disposal of specified derivatives relevant interest (if applicable)
Type of affected derivative:
Not applicable
Class of underlying financial products:
Not applicable
Details of affected derivative-
The notional value of the derivative (if any) or the notional amount of
underlying financial products (if any):
Not applicable
A statement as to whether the derivative is cash settled or physically
settled:
Maturity date of the derivative (if any):
Not applicable
Expiry date of the derivative(if any):
Not applicable
The price specified in the terms of the derivative (if any):
Not applicable
Any other details needed to understand how the amount of the
consideration payable under the derivative or the value of the
derivative is affected by the value of the underlying financial products:
Not applicable
For that derivative,-
Parties to the derivative:
Not applicable
If the director or senior manager is not a party to the derivative, the
nature of the relevant interest in the derivative:
Not applicable
Details of transactions giving rise to acquisition or disposal
Total number of transactions to which notice relates: 2

Details of transactions requiring disclosure-
Date of transaction:22 April 202426 April 2024
Nature of transaction:
Off-market transfer of shares from
Jeffrey Kenneth Greenslade
Acquisition of
shares under
the retail
component of
Heartland’s
underwritten
NZ$105
million
accelerated
non
renounceable
entitlement
offer
announced on
8 April 2024
Name of any other party or parties to the transaction (if known):
Frederick McHardy Greenslade and
Katherine Lily Greenslade
Heartland
Group
The consideration, expressed in New Zealand dollars, paid or received
for the acquisition or disposal. If the consideration was not in cash and
cannot be readily by converted into a cash value, describe the
consideration:
Nil$350,440.00
Number of financial products to which the transaction related: 100,000350,440
If the issuer has a financial products trading policy that prohibits
directors or senior managers from trading during any period without
written clearance (a closed period) include the following details—
Whether relevant interests were acquired or disposed of during a closed peri No
Whether prior written clearance was provided to allow the acquisition
or disposal to proceed during the closed period:
Not applicable
Date of the prior written clearance (if any):
Not applicable
Summary of other relevant interests after acquisition or disposal:
Class of quoted financial products:Not applicable
Nature of relevant interest:Not applicable
For that relevant interest,-
Number held in class:Not applicable
Current registered holder(s):Not applicable
For a derivative relevant interest,-
Type of derivative:Not applicable
Details of derivative,-
The notional value of the derivative (if any) or the notional amount of
underlying financial products (if any):
Not applicable
A statement as to whether the derivative is cash settled or physically
settled:
Not applicable
Maturity date of the derivative (if any):
Not applicable
Expiry date of the derivative (if any):
Not applicable
The price's specified terms (if any):
Not applicable
Any other details needed to understand how the amount of the
consideration payable under the derivative or the value of the
derivative is affected by the value of the underlying financial products:
Not applicable
For that derivative relevant interest,-
Parties to the derivative:
Not applicable
If the director or senior manager is not a party to the derivative, the
nature of the relevant interest in the derivative:
Not applicable

Certification
I, certify that, to the best of my knowledge and belief, the information
contained in this disclosure is correct and that I am duly authorised to
make this disclosure by all persons for whom it is made.
Signature of director or officer:
Date of signature:
or
Signature of person authorised to sign on behalf of director or officer:
Date of signature:
3 May 2024
Name and title of authorised person:Phoebe Gibbons, General Counsel

Ongoing Disclosure Notice
Disclosure of Directors and Senior Managers Relevant Interests
Sections 297(2) and 298(2), Financial Markets Conduct Act 2013
To NZX Limited; and
Name of listed issuer:
Heartland Group Holdings Limited
Date this disclosure made:
3 May 2024
Date of last disclosure:
27 March 2024
Director or senior manager giving disclosure
Full name(s):
Edward John Harvey
Name of listed issuer:
Heartland Group Holdings Limited
Name of related body corporate (if applicable):
Not applicable
Position held in listed issuer:
Director
Summary of acquisition or disposal of relevant interest (excluding specified derivatives)
Class of affected quoted financial products:
Ordinary shares in Heartland Group
Holdings Limited (NZX/ASX: HGH)
Nature of the affected relevant interest(s):
Beneficial Owner
For that relevant interest-
Number held in class before acquisition or disposal:
173,230
Number held in class after acquisition or disposal:
198,519
Current registered holder(s):
Susan Shirley Harvey
Registered holder(s) once transfers are registered:
Not applicable
Summary of acquisition or disposal of specified derivatives relevant interest (if applicable)
Type of affected derivative:
Not applicable
Class of underlying financial products:
Not applicable
Details of affected derivative-
The notional value of the derivative (if any) or the notional amount of underlying
financial products (if any):
Not applicable
A statement as to whether the derivative is cash settled or physically settled:
Not applicable
Maturity date of the derivative (if any):
Not applicable
Expiry date of the derivative(if any):
Not applicable
The price specified in the terms of the derivative (if any):
Not applicable
Any other details needed to understand how the amount of the consideration payable
under the derivative or the value of the derivative is affected by the value of the
underlying financial products:
Not applicable
For that derivative,-
Parties to the derivative:
Not applicable
If the director or senior manager is not a party to the derivative, the nature of the
relevant interest in the derivative:
Not applicable
Details of transactions giving rise to acquisition or disposal
Total number of transactions to which notice relates: 1

Details of transactions requiring disclosure-
Date of transaction:26 April 2024
Nature of transaction:
Acquisition of shares under the retail
component of Heartland’s
underwritten NZ$105 million
accelerated non renounceable
entitlement offer announced on 8
April 2024.
Name of any other party or parties to the transaction (if known):Not applicable
The consideration, expressed in New Zealand dollars, paid or received for the
acquisition or disposal. If the consideration was not in cash and cannot be readily by
converted into a cash value, describe the consideration:
$25,289.00
Number of financial products to which the transaction related: 25,289
If the issuer has a financial products trading policy that prohibits directors or senior
managers from trading during any period without written clearance (a closed period)
include the following details—
Whether relevant interests were acquired or disposed of during a closed period:No
Whether prior written clearance was provided to allow the acquisition or disposal to
proceed during the closed period:
Not applicable
Date of the prior written clearance (if any):
Not applicable
Summary of other relevant interests after acquisition or disposal:
Class of quoted financial products:Not applicable
Nature of relevant interest:Not applicable
For that relevant interest,-
Number held in class:Not applicable
Current registered holder(s):Not applicable
For a derivative relevant interest,-
Type of derivative:Not applicable
Details of derivative,-
The notional value of the derivative (if any) or the notional amount of underlying
financial products (if any):
Not applicable
A statement as to whether the derivative is cash settled or physically settled:
Not applicable
Maturity date of the derivative (if any):
Not applicable
Expiry date of the derivative (if any):
Not applicable
The price's specified terms (if any):
Not applicable
Any other details needed to understand how the amount of the consideration payable
under the derivative or the value of the derivative is affected by the value of the
underlying financial products:
Not applicable
For that derivative relevant interest,-
Parties to the derivative:
Not applicable
If the director or senior manager is not a party to the derivative, the nature of the
relevant interest in the derivative:
Not applicable
Certification
I, certify that, to the best of my knowledge and belief, the information contained in this
disclosure is correct and that I am duly authorised to make this disclosure by all
persons for whom it is made.
Signature of director or officer:
Date of signature:
or

Signature of person authorised to sign on behalf of director or officer:
Date of signature:
3 May 2024
Name and title of authorised person:Phoebe Gibbons, General Counsel

Ongoing Disclosure Notice
Disclosure of Directors and Senior Managers Relevant Interests
Sections 297(2) and 298(2), Financial Markets Conduct Act 2013
To NZX Limited; and
Name of listed issuer:
Heartland Group Holdings Limited
Date this disclosure made:
3 May 2024
Date of last disclosure:
8 May 2023
Director or senior manager giving disclosure
Full name(s):
Kate Morrison
Name of listed issuer:
Heartland Bank Limited
Name of related body corporate (if applicable):
Not applicable
Position held in listed issuer:
Director
Summary of acquisition or disposal of relevant interest (excluding specified derivatives)
Class of affected quoted financial products:
Ordinary shares in Heartland Group
Holdings Limited (NZX/ASX: HGH)
Nature of the affected relevant interest(s):
(a)
Regis
tered Holder and Benefic
ial
O
wner (b) Beneficial Owner
For that relevant interest-
Number held in class before acquisition or disposal:
(a)
55,
000 (b) 53,088.48
Number held in class after acquisition or disposal:
(a)
71,
058 (b) 68,588.76
Current registered holder(s):
(a
) Ka
thryn Mitchell (Morrison) (b
)
S
haresies Nominee Limited
Registered holder(s) once transfers are registered:
Not applicable
Summary of acquisition or disposal of specified derivatives relevant interest (if applicable)
Type of affected derivative:
Not applicable
Class of underlying financial products:
Not applicable
Details of affected derivative-
The notional value of the derivative (if any) or the notional amount of underlying
financial products (if any):
Not applicable
A statement as to whether the derivative is cash settled or physically settled:
Not applicable
Maturity date of the derivative (if any):
Not applicable
Expiry date of the derivative(if any):
Not applicable
The price specified in the terms of the derivative (if any):
Not applicable
Any other details needed to understand how the amount of the consideration payable
under the derivative or the value of the derivative is affected by the value of the
underlying financial products:
Not applicable
For that derivative,-
Parties to the derivative:
Not applicable
If the director or senior manager is not a party to the derivative, the nature of the
relevant interest in the derivative:
Not applicable
Details of transactions giving rise to acquisition or disposal
Total number of transactions to which notice relates: 2

Details of transactions requiring disclosure-
Date of transaction:26 April 2024
Nature of transaction:
Acquisition of shares under the retail
component of Heartland’s
underwritten NZ$105 million
accelerated non renounceable
entitlement offer announced on 8
April 2024
Name of any other party or parties to the transaction (if known):Heartland Group Holdings Limited
The consideration, expressed in New Zealand dollars, paid or received for the
acquisition or disposal. If the consideration was not in cash and cannot be readily by
converted into a cash value, describe the consideration:
(a)
$16,
058 (b) $15,500.29
Number of financial products to which the transaction related: (a)
16,
058 (b) 15,500.29
If the issuer has a financial products trading policy that prohibits directors or senior
managers from trading during any period without written clearance (a closed period)
include the following details—
Whether relevant interests were acquired or disposed of during a closed period:No
Whether prior written clearance was provided to allow the acquisition or disposal to
proceed during the closed period:
Not applicable
Date of the prior written clearance (if any):
Not applicable
Summary of other relevant interests after acquisition or disposal:
Class of quoted financial products:
Unsecured, subordinated Notes in
Heartland Bank Limited (NZX: HBL)
Nature of relevant interest:
Registered Holder and Beneficial
Owner
For that relevant interest,-
Number held in class:10,000
Current registered holder(s):Kathryn Mitchell (Morrison)
For a derivative relevant interest,-
Type of derivative:Not applicable
Details of derivative,-
The notional value of the derivative (if any) or the notional amount of underlying
financial products (if any):
Not applicable
A statement as to whether the derivative is cash settled or physically settled:Not applicable
Maturity date of the derivative (if any):Not applicable
Expiry date of the derivative (if any):Not applicable
The price's specified terms (if any):Not applicable
Any other details needed to understand how the amount of the consideration payable
under the derivative or the value of the derivative is affected by the value of the
underlying financial products:
Not applicable
For that derivative relevant interest,-
Parties to the derivative:
Not applicable
If the director or senior manager is not a party to the derivative, the nature of the
relevant interest in the derivative:
Not applicable
Certification
I, certify that, to the best of my knowledge and belief, the information contained in this
disclosure is correct and that I am duly authorised to make this disclosure by all
persons for whom it is made.
Signature of director or officer:
Date of signature:

or
Signature of person authorised to sign on behalf of director or officer:
Date of signature:
3 May 2024
Name and title of authorised person:Phoebe Gibbons, General Counsel

Ongoing Disclosure Notice
Disclosure of Directors and Senior Managers Relevant Interests
Sections 297(2) and 298(2), Financial Markets Conduct Act 2013
To NZX Limited; and
Name of listed issuer:
Heartland Group Holdings Limited
Date this disclosure made:
3 May 2024
Date of last disclosure:
6 October 2021
Director or senior manager giving disclosure
Full name(s):
Shelley Maree Ruha
Name of listed issuer:
Heartland Group Holdings Limited
Name of related body corporate (if applicable):
Heartland Bank Limited
Position held in listed issuer:
Director
Summary of acquisition or disposal of relevant interest (excluding specified derivatives)
Class of affected quoted financial products:
Ordinary shares in Heartland Group
Holdings Limited (NZX/ASX: HGH)
Nature of the affected relevant interest(s):
Beneficial Owner
For that relevant interest-
Number held in class before acquisition or disposal:
158,536
Number held in class after acquisition or disposal:
200,000
Current registered holder(s):
Sam Hamana Tiakiwai Ruha
Registered holder(s) once transfers are registered:
Not applicable
Summary of acquisition or disposal of specified derivatives relevant interest (if applicable)
Type of affected derivative:
Not applicable
Class of underlying financial products:
Not applicable
Details of affected derivative-
The notional value of the derivative (if any) or the notional amount of underlying
financial products (if any):
Not applicable
A statement as to whether the derivative is cash settled or physically settled:
Not applicable
Maturity date of the derivative (if any):
Not applicable
Expiry date of the derivative(if any):
Not applicable
The price specified in the terms of the derivative (if any):
Not applicable
Any other details needed to understand how the amount of the consideration payable
under the derivative or the value of the derivative is affected by the value of the
underlying financial products:
Not applicable
For that derivative,-
Parties to the derivative:
Not applicable
If the director or senior manager is not a party to the derivative, the nature of the
relevant interest in the derivative:
Not applicable
Details of transactions giving rise to acquisition or disposal
Total number of transactions to which notice relates: 1

Details of transactions requiring disclosure-
Date of transaction:26 April 2024
Nature of transaction:
Acquisition of shares under the retail
component of Heartland’s
underwritten NZ$105 million
accelerated non renounceable
entitlement offer announced on 8
April 2024
Name of any other party or parties to the transaction (if known):Heartland Group Holdings Limited
The consideration, expressed in New Zealand dollars, paid or received for the
acquisition or disposal. If the consideration was not in cash and cannot be readily by
converted into a cash value, describe the consideration:
$41,464.00
Number of financial products to which the transaction related: 41,464
If the issuer has a financial products trading policy that prohibits directors or senior
managers from trading during any period without written clearance (a closed period)
include the following details—
Whether relevant interests were acquired or disposed of during a closed period:No
Whether prior written clearance was provided to allow the acquisition or disposal to
proceed during the closed period:
Not applicable
Date of the prior written clearance (if any):
Not applicable
Summary of other relevant interests after acquisition or disposal:
Class of quoted financial products:Not applicable
Nature of relevant interest:Not applicable
For that relevant interest,-
Number held in class:Not applicable
Current registered holder(s):Not applicable
For a derivative relevant interest,-
Type of derivative:Not applicable
Details of derivative,-
The notional value of the derivative (if any) or the notional amount of underlying
financial products (if any):
Not applicable
A statement as to whether the derivative is cash settled or physically settled:
Not applicable
Maturity date of the derivative (if any):
Not applicable
Expiry date of the derivative (if any):
Not applicable
The price's specified terms (if any):
Not applicable
Any other details needed to understand how the amount of the consideration payable
under the derivative or the value of the derivative is affected by the value of the
underlying financial products:
Not applicable
For that derivative relevant interest,-
Parties to the derivative:
Not applicable
If the director or senior manager is not a party to the derivative, the nature of the
relevant interest in the derivative:
Not applicable
Certification
I, certify that, to the best of my knowledge and belief, the information contained in this
disclosure is correct and that I am duly authorised to make this disclosure by all
persons for whom it is made.
Signature of director or officer:
Date of signature:
or

Signature of person authorised to sign on behalf of director or officer:
Date of signature:
3 May 2024
Name and title of authorised person:Phoebe Gibbons, General Counsel